Global Drugs of Nervous System Market Research Report 2017-2022 By Players, Regions, Product Types & Applications

July 2017 | 114 pages | ID: G818878F97AEN
DataMarketResearch (DMR)

Abstracts

The global Drugs of Nervous System market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report offers an overview of the market trends, drivers, and barriers with respect to the Drugs of Nervous System market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes Drugs of Nervous System market by Product Antiparkinsonism drugs, by Product Antimyasthenics, by Product Antiepileptics, by Product Cerebrovascular disease drugs, by Product Sedative-hypnotic drugs and application. A detailed analysis of key players, along with key growth strategies adopted by them is also covered in this report on Drugs of Nervous System market.

This report focus Global market, it covers details players regions product type and other details as following:

Key Players

• MSD PHARMA (SINGAPORE) PTE. LTD.Italy
• Orion Corporation Finland
• Gedeon Richter Plc. Hungary
• Novartis Farma S.P.A. Italy
• Gedeon Richter Plc.Hungary
• Janssen Pharmaceutica N.V. Belgium
• Sanofi Aventis GmbH France
• Taiwan Biotech Co.Ltd
• GlaxoSmithKline Pharmaceuticals S.A.Poland
• Actavis hf. Iceland
• UCB Pharma S.A.Belgium
• Janssen-Cilag AG Puerto Rico
• Bayer Vital GmbH Germany
• Pfizer Pharmaceuticals Inc.
• PATHEON AUSTRIA GMBH & CO. KG AT Linz
• ALKALOIDA CHEMICAL Tiszavasvari
• Siegfried Ltd CH 4800 Zofingen
• KATWIJK CHEMIE BV NL BA Katwijk ZH
• F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore
• Ergypharm FR 67452 Mundolsheim
• HARMAN FINOCHEM LIMITED IN Mumbai
• Sumitomo Dainippon Pharma Co.,Ltd.
• SANWA KAGAKU KENKYUSHO CO.,LTD.
• 大鵬薬品工業株式会社
• 丸石製薬株式会社
• BIONPHARMA INC
• BARR
• SANDOZ
• SANDOZ
• VALEANT

Key Regions

• United States
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Others
• China
• Japan
• India
• Southeast Asia
• Others

Key Product Type

Drugs of Nervous System Market, by Product Category01

• L-Dopa
• Carbidopa
• Benserazide
• Sinemet
• Selegiline
• Amantadine
• Bromocriptine
• Pergolide
• Artane

Drugs of Nervous System Market, by Product Antimyasthenics

• Neostigmine
• Neostigmine Methylsulfate
• Pyridostigmine Bromide
• Galanthamine
• Edrophonium Chloride
• Ambestigmin
• Felbamate
• Levetiracetam
• Topamax

Drugs of Nervous System Market, by Product Antiepileptics

• Phenytoin Sodium
• Carbamazepine
• Phenobarbital
• Primidone
• Ethosuximide
• Sodium valproate
• Clonazepam
• Trimethadione
• Lamotrigine

Drugs of Nervous System Market, by Product Cerebrovascular disease drugs

• Nimodipine
• Carfergot
• Mannitol
• Acetazolamide
• Piracetam
• Captodiamine
• Piperilate
• Chlormezanone
• Trimeprazine Tartrate

Drugs of Nervous System Market, by Product Sedative-hypnotic drugs

• Diazepam
• Chlordiazepoxide
• Oxazepam
• Nitrazepam
• Flunitrazepam
• Estazolam
• Lorazepam
• Meprobamate
• Hydroxyzine

Key Consumers (End User)

Drugs of Nervous System Market, by Consumer

• Pharmacy
• Hospital
• Department of psychiatry
• Department of Encephalopathy
• Department of neurology

Contents

CHAPTER ONE, METHODOLOGY AND DATA SOURCE

1.1 Methodology/Research Approach
  1.1.1 Research Programs/Design
  1.1.2 Market Size Estimation
  1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
  1.2.1 Secondary Sources
  1.2.2 Primary Sources
1.3 Disclaimer

CHAPTER TWO DRUGS OF NERVOUS SYSTEM MARKET OVERVIEW

2.1 Market Coverage
2.2 Global Drugs of Nervous System Market Sales Volume Revenue and Price 2012-2022

CHAPTER THREE, DRUGS OF NERVOUS SYSTEM BY KEY PLAYERS 2012-2022

3.1 Global Drugs of Nervous System Sales Volume Market Share by Key Players 2012-2022
3.2 Global Drugs of Nervous System Revenue Share by Key Players 2012-2022
3.3 Global Key Players Drugs of Nervous System Key Product Model and Market Performance
3.4 Global Key Players Drugs of Nervous System Key Target Consumers and Market Performance

CHAPTER FOUR, DRUGS OF NERVOUS SYSTEM BY REGIONS 2012-2022

4.1 Global Drugs of Nervous System Sales Market Share by Regions 2012-2022
4.2 Global Drugs of Nervous System Revenue Market Share by Regions 2012-2022
4.3 Global Drugs of Nervous System Price by Regions 2012-2022
4.4 United States
4.5 Europe
  4.5.1 Germany
  4.5.2 United Kingdom
  4.5.3 France
  4.5.4 Italy
  4.5.5 Spain
  4.5.6 Russia
  4.5.7 Others in Europe
4.6 China
4.7 Japan
4.8 India
4.9 Southeast Asia
4.10 Others

CHAPTER FIVE DRUGS OF NERVOUS SYSTEM MARKET BY PRODUCT TYPES

5.1 Drugs of Nervous System, by Product Antiparkinsonism drugs2012-2022
  5.1.1 Global Drugs of Nervous System Sales Market Share by Product Antiparkinsonism drugs2012-2022
  5.1.2 Global Drugs of Nervous System Revenue Market Share by Product Antiparkinsonism drugs2012-2022
  5.1.3 Global Drugs of Nervous System Price by Product Antiparkinsonism drugs2012-2022
  5.1.4 L-Dopa
  5.1.5 Carbidopa
  5.1.6 Benserazide
  5.1.7 Sinemet
  5.1.8 Selegiline
  5.1.9 Amantadine
  5.1.10 Bromocriptine
  5.1.11 Pergolide
  5.1.12 Artane
5.2 Drugs of Nervous System, by Product Antimyasthenics 2012-2022
  5.2.1 Global Drugs of Nervous System Sales Market Share by Product Antimyasthenics 2012-2022
  5.2.2 Global Drugs of Nervous System Revenue Market Share by Product Antimyasthenics 2012-2022
  5.2.3 Global Drugs of Nervous System Price by Product Antimyasthenics 2012-2022
  5.2.4 Neostigmine
  5.2.5 Neostigmine Methylsulfate
  5.2.6 Pyridostigmine Bromide
  5.2.7 Galanthamine
  5.2.8 Edrophonium Chloride
  5.2.9 Ambestigmin
5.3 Drugs of Nervous System, by Product Antiepileptics 2012-2022
  5.3.1 Global Drugs of Nervous System Sales Market Share by Product Antiepileptics 2012-2022
  5.3.2 Global Drugs of Nervous System Revenue Market Share by Product Antiepileptics 2012-2022
  5.3.3 Global Drugs of Nervous System Price by Product Antiepileptics 2012-2022
  5.3.4 Phenytoin Sodium
  5.3.5 Carbamazepine
  5.3.6 Phenobarbital
  5.3.7 Primidone
  5.3.8 Ethosuximide
  5.3.9 Sodium valproate
  5.3.10 Clonazepam
  5.3.11 Trimethadione
  5.3.12 Lamotrigine
  5.3.13 Sultiame
  5.3.14 Felbamate
  5.3.15 Levetiracetam
  5.3.16 Topamax
5.4 Drugs of Nervous System, by Product Cerebrovascular disease drugs 2012-2022
  5.4.1 Global Drugs of Nervous System Sales Market Share by Product Cerebrovascular disease drugs 2012-2022
  5.4.2 Global Drugs of Nervous System Revenue Market Share by Product Cerebrovascular disease drugs 2012-2022
  5.4.3 Global Drugs of Nervous System Price by Product Cerebrovascular disease drugs 2012-2022
  5.4.4 Nimodipine
  5.4.5 Carfergot
  5.4.6 Mannitol
  5.4.7 Acetazolamide
  5.4.8 Piracetam
5.5 Drugs of Nervous System, by Product Sedative-hypnotic drugs 2012-2022
  5.5.1 Global Drugs of Nervous System Sales Market Share by Product Sedative-hypnotic drugs 2012-2022
  5.5.2 Global Drugs of Nervous System Revenue Market Share by Product Sedative-hypnotic drugs 2012-2022
  5.5.3 Global Drugs of Nervous System Price by Product Sedative-hypnotic drugs 2012-2022
  5.5.4 Diazepam
  5.5.5 Chlordiazepoxide
  5.5.6 Oxazepam
  5.5.7 Nitrazepam
  5.5.8 Flunitrazepam
  5.5.9 Estazolam
  5.5.10 Lorazepam
  5.5.11 Meprobamate
  5.5.12 Hydroxyzine
  5.5.13 Captodiamine
  5.5.14 Piperilate
  5.5.15 Chlormezanone
  5.5.16 Trimeprazine Tartrate
  5.5.17 Trimetozine
  5.5.18 Oryzanol
  5.5.19 Benzoctamine
  5.5.20 Gastrodine
  5.4.21 Glutethimide
5.6 Drugs of Nervous System, by Product Others 2012-2022
  5.6.1 Global Drugs of Nervous System Sales Market Share by Product Sedative-hypnotic drugs 2012-2022
  5.6.2 Global Drugs of Nervous System Revenue Market Share by Product Sedative-hypnotic drugs 2012-2022
  5.6.3 Global Drugs of Nervous System Price by Product Sedative-hypnotic drugs 2012-2022
  5.6.4 Citicoline
  5.6.5 Nikethamide
  5.6.6 Lobeline
  5.6.7 Piracetam
  5.6.8 Ligustrazine
  5.6.9 Flunarizine
  5.6.10 Cerebroprotein Hydrolysate
  5.6.11 Sodium Aescinate
  5.6.12 Troxerutin
  5.6.13 Captodiamine

CHAPTER SIX, GLOBAL KEY PLAYERS PROFILE

6.1 MSD PHARMA (SINGAPORE) PTE. LTD.Italy
  6.1.1 MSD PHARMA (SINGAPORE) PTE. LTD.Italy Company Details and Competitors
  6.1.2 MSD PHARMA (SINGAPORE) PTE. LTD.Italy Key Drugs of Nervous System Models and Performance
  6.1.3 MSD PHARMA (SINGAPORE) PTE. LTD.Italy Drugs of Nervous System Business SWOT Analysis and Forecast
  6.1.4 MSD PHARMA (SINGAPORE) PTE. LTD.Italy Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.2 Orion Corporation Finland
  6.2.1 Orion Corporation Finland Company Details and Competitors
  6.2.2 Orion Corporation Finland Key Drugs of Nervous System Models and Performance
  6.2.3 Orion Corporation Finland Drugs of Nervous System Business SWOT Analysis and Forecast
  6.2.4 Orion Corporation Finland Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.3 Gedeon Richter Plc. Hungary
  6.3.1 Gedeon Richter Plc. Hungary Company Details and Competitors
  6.3.2 Gedeon Richter Plc. Hungary Key Drugs of Nervous System Models and Performance
  6.3.3 Gedeon Richter Plc. Hungary Drugs of Nervous System Business SWOT Analysis and Forecast
  6.3.4 Gedeon Richter Plc. Hungary Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.4 Novartis Farma S.P.A. Italy
  6.4.1 Novartis Farma S.P.A. Italy Company Details and Competitors
  6.4.2 Novartis Farma S.P.A. Italy Key Drugs of Nervous System Models and Performance
  6.4.3 Novartis Farma S.P.A. Italy Drugs of Nervous System Business SWOT Analysis and Forecast
  6.4.4 Novartis Farma S.P.A. Italy Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.5 Gedeon Richter Plc.Hungary
  6.5.1 Gedeon Richter Plc.Hungary Company Details and Competitors
  6.5.2 Gedeon Richter Plc.Hungary Key Drugs of Nervous System Models and Performance
  6.5.3 Gedeon Richter Plc.Hungary Drugs of Nervous System Business SWOT Analysis and Forecast
  6.5.4 Gedeon Richter Plc.Hungary Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.6 Janssen Pharmaceutica N.V. Belgium
  6.6.1 Janssen Pharmaceutica N.V. Belgium Company Details and Competitors
  6.6.2 Janssen Pharmaceutica N.V. Belgium Key Drugs of Nervous System Models and Performance
  6.6.3 Janssen Pharmaceutica N.V. Belgium Drugs of Nervous System Business SWOT Analysis and Forecast
  6.6.4 Janssen Pharmaceutica N.V. Belgium Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.7 Sanofi Aventis GmbH France
  6.7.1 Sanofi Aventis GmbH France Company Details and Competitors
  6.7.2 Sanofi Aventis GmbH France Key Drugs of Nervous System Models and Performance
  6.7.3 Sanofi Aventis GmbH France Drugs of Nervous System Business SWOT Analysis and Forecast
  6.7.4 Sanofi Aventis GmbH France Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.8 Taiwan Biotech Co.Ltd
  6.8.1 Taiwan Biotech Co.Ltd Company Details and Competitors
  6.8.2 Taiwan Biotech Co.Ltd Key Drugs of Nervous System Models and Performance
  6.8.3 Taiwan Biotech Co.Ltd Drugs of Nervous System Business SWOT Analysis and Forecast
  6.8.4 Taiwan Biotech Co.Ltd Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.9 GlaxoSmithKline Pharmaceuticals S.A.Poland
  6.9.1 GlaxoSmithKline Pharmaceuticals S.A.Poland Company Details and Competitors
  6.9.2 GlaxoSmithKline Pharmaceuticals S.A.Poland Key Drugs of Nervous System Models and Performance
  6.9.3 GlaxoSmithKline Pharmaceuticals S.A.Poland Drugs of Nervous System Business SWOT Analysis and Forecast
  6.9.4 GlaxoSmithKline Pharmaceuticals S.A.Poland Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.10 Actavis hf. Iceland
  6.10.1 Actavis hf. Iceland Company Details and Competitors
  6.10.2 Actavis hf. Iceland Key Drugs of Nervous System Models and Performance
  6.10.3 Actavis hf. Iceland Drugs of Nervous System Business SWOT Analysis and Forecast
  6.10.4 Actavis hf. Iceland Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.11 UCB Pharma S.A.Belgium
  6.11.1 UCB Pharma S.A.Belgium Company Details and Competitors
  6.11.2 UCB Pharma S.A.Belgium Key Drugs of Nervous System Models and Performance
  6.11.3 UCB Pharma S.A.Belgium Drugs of Nervous System Business SWOT Analysis and Forecast
  6.11.4 UCB Pharma S.A.Belgium Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.12 Janssen-Cilag AG Puerto Rico
  6.12.1 Janssen-Cilag AG Puerto Rico Company Details and Competitors
  6.12.2 Janssen-Cilag AG Puerto Rico Key Drugs of Nervous System Models and Performance
  6.12.3 Janssen-Cilag AG Puerto Rico Drugs of Nervous System Business SWOT Analysis and Forecast
  6.12.4 Janssen-Cilag AG Puerto Rico Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.13 Bayer Vital GmbH Germany
  6.13.1 Bayer Vital GmbH Germany Company Details and Competitors
  6.13.2 Bayer Vital GmbH Germany Key Drugs of Nervous System Models and Performance
  6.13.3 Bayer Vital GmbH Germany Drugs of Nervous System Business SWOT Analysis and Forecast
  6.13.4 Bayer Vital GmbH Germany Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.14 Pfizer Pharmaceuticals Inc.
  6.14.1 Pfizer Pharmaceuticals Inc. Company Details and Competitors
  6.14.2 Pfizer Pharmaceuticals Inc. Key Drugs of Nervous System Models and Performance
  6.14.3 Pfizer Pharmaceuticals Inc. Drugs of Nervous System Business SWOT Analysis and Forecast
  6.14.4 Pfizer Pharmaceuticals Inc. Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.15 PATHEON AUSTRIA GMBH & CO. KG AT Linz
  6.15.1 PATHEON AUSTRIA GMBH & CO. KG AT Linz Company Details and Competitors
  6.15.2 PATHEON AUSTRIA GMBH & CO. KG AT Linz Key Drugs of Nervous System Models and Performance
  6.15.3 PATHEON AUSTRIA GMBH & CO. KG AT Linz Drugs of Nervous System Business SWOT Analysis and Forecast
  6.15.4 PATHEON AUSTRIA GMBH & CO. KG AT Linz Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.16 ALKALOIDA CHEMICAL Tiszavasvari
  6.16.1 ALKALOIDA CHEMICAL Tiszavasvari Company Details and Competitors
  6.16.2 ALKALOIDA CHEMICAL Tiszavasvari Key Drugs of Nervous System Models and Performance
  6.16.3 ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Business SWOT Analysis and Forecast
  6.16.4 ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.17 Siegfried Ltd CH 4800 Zofingen
  6.17.1 Siegfried Ltd CH 4800 Zofingen Company Details and Competitors
  6.17.2 Siegfried Ltd CH 4800 Zofingen Key Drugs of Nervous System Models and Performance
  6.17.3 Siegfried Ltd CH 4800 Zofingen Drugs of Nervous System Business SWOT Analysis and Forecast
  6.17.4 Siegfried Ltd CH 4800 Zofingen Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.18 KATWIJK CHEMIE BV NL BA Katwijk ZH
  6.18.1 KATWIJK CHEMIE BV NL BA Katwijk ZH Company Details and Competitors
  6.18.2 KATWIJK CHEMIE BV NL BA Katwijk ZH Key Drugs of Nervous System Models and Performance
  6.18.3 KATWIJK CHEMIE BV NL BA Katwijk ZH Drugs of Nervous System Business SWOT Analysis and Forecast
  6.18.4 KATWIJK CHEMIE BV NL BA Katwijk ZH Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.19 F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore
  6.19.1 F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Company Details and Competitors
  6.19.2 F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Key Drugs of Nervous System Models and Performance
  6.19.3 F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Drugs of Nervous System Business SWOT Analysis and Forecast
  6.19.4 F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.20 Ergypharm FR 67452 Mundolsheim
  6.20.1 Ergypharm FR 67452 Mundolsheim Company Details and Competitors
  6.20.2 Ergypharm FR 67452 Mundolsheim Key Drugs of Nervous System Models and Performance
  6.20.3 Ergypharm FR 67452 Mundolsheim Drugs of Nervous System Business SWOT Analysis and Forecast
  6.20.4 Ergypharm FR 67452 Mundolsheim Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.21 HARMAN FINOCHEM LIMITED IN Mumbai
  6.21.1 HARMAN FINOCHEM LIMITED IN Mumbai Company Details and Competitors
  6.21.2 HARMAN FINOCHEM LIMITED IN Mumbai Key Drugs of Nervous System Models and Performance
  6.21.3 HARMAN FINOCHEM LIMITED IN Mumbai Drugs of Nervous System Business SWOT Analysis and Forecast
  6.21.4 HARMAN FINOCHEM LIMITED IN Mumbai Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.22 Sumitomo Dainippon Pharma Co.,Ltd.
  6.22.1 Sumitomo Dainippon Pharma Co.,Ltd. Company Details and Competitors
  6.22.2 Sumitomo Dainippon Pharma Co.,Ltd. Key Drugs of Nervous System Models and Performance
  6.22.3 Sumitomo Dainippon Pharma Co.,Ltd. Drugs of Nervous System Business SWOT Analysis and Forecast
  6.22.4 Sumitomo Dainippon Pharma Co.,Ltd. Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.23 SANWA KAGAKU KENKYUSHO CO.,LTD.
  6.23.1 SANWA KAGAKU KENKYUSHO CO.,LTD. Company Details and Competitors
  6.23.2 SANWA KAGAKU KENKYUSHO CO.,LTD. Key Drugs of Nervous System Models and Performance
  6.23.3 SANWA KAGAKU KENKYUSHO CO.,LTD. Drugs of Nervous System Business SWOT Analysis and Forecast
  6.23.4 SANWA KAGAKU KENKYUSHO CO.,LTD. Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.24 大鵬薬品工業株式会社
  6.24.1 大鵬薬品工業株式会社 Company Details and Competitors
  6.24.2 大鵬薬品工業株式会社 Key Drugs of Nervous System Models and Performance
  6.24.3 大鵬薬品工業株式会社 Drugs of Nervous System Business SWOT Analysis and Forecast
  6.24.4 大鵬薬品工業株式会社 Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.25 丸石製薬株式会社
  6.25.1 丸石製薬株式会社 Company Details and Competitors
  6.25.2 丸石製薬株式会社 Key Drugs of Nervous System Models and Performance
  6.25.3 丸石製薬株式会社 Drugs of Nervous System Business SWOT Analysis and Forecast
  6.25.4 丸石製薬株式会社 Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.26 BIONPHARMA INC
  6.26.1 BIONPHARMA INC Company Details and Competitors
  6.26.2 BIONPHARMA INC Key Drugs of Nervous System Models and Performance
  6.26.3 BIONPHARMA INC Drugs of Nervous System Business SWOT Analysis and Forecast
  6.26.4 BIONPHARMA INC Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.27 BARR
  6.27.1 BARR Company Details and Competitors
  6.27.2 BARR Key Drugs of Nervous System Models and Performance
  6.27.3 BARR Drugs of Nervous System Business SWOT Analysis and Forecast
  6.27.4 BARR Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.28 SANDOZ
  6.28.1 SANDOZ Company Details and Competitors
  6.28.2 SANDOZ Key Drugs of Nervous System Models and Performance
  6.28.3 SANDOZ Drugs of Nervous System Business SWOT Analysis and Forecast
  6.28.4 SANDOZ Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.29 SANDOZ
  6.29.1 SANDOZ Company Details and Competitors
  6.29.2 SANDOZ Key Drugs of Nervous System Models and Performance
  6.29.3 SANDOZ Drugs of Nervous System Business SWOT Analysis and Forecast
  6.29.4 SANDOZ Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
6.30 VALEANT
  6.30.1 VALEANT Company Details and Competitors
  6.30.2 VALEANT Key Drugs of Nervous System Models and Performance
  6.30.3 VALEANT Drugs of Nervous System Business SWOT Analysis and Forecast
  6.30.4 VALEANT Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin

CHAPTER SEVEN, DRUGS OF NERVOUS SYSTEM BY APPLIANCE (2012-2022)

7.1 Global Drugs of Nervous System Sales Market Share by Appliance (2012-2022)
7.2 Pharmacy
7.3 Hospital
7.4 Department of psychiatry
7.5 Department of Encephalopathy
7.6 Department of neurology
7.7 Consuming Habit and Preference

CHAPTER EIGHT, INDUSTRY CHAIN AND SUPPLY CHAIN

8.1 Drugs of Nervous System Industry Chain Structure
  8.1.1 R&D
  8.1.2 Raw Materials (Components)
  8.1.3 Manufacturing Plants
  8.1.4 Regional Trading (Import Export and Local Sales)
  8.1.5 Online Sales Channel
  8.1.6 Offline Channel
  8.1.7 End Users
8.2 Drugs of Nervous System Manufacturing
  8.2.1 Key Components
  8.2.2 Assembly Manufacturing
8.3 Consumer Preference
8.4 Behavioral Habits
8.5 Marketing Environment

CHAPTER NINE, DEVELOPMENT TREND AND RESEARCH CONCLUSION

9.1 Development Trend
9.2 Research Conclusion

List Of Tables

LIST OF TABLES AND FIGURES

Table Global Drugs of Nervous System Sales Volume (MT) Revenue (Million USD) and Price (USD/T) 2012-2022
Figure Global Drugs of Nervous System Revenue (Million USD) and Growth Rate 2012-2022
Figure Global Drugs of Nervous System Sales Volume (MT) and Growth Rate 2012-2022
Table Global Drugs of Nervous System Sales Volume (MT) by Key Players 2012-2022
Table Global Drugs of Nervous System Sales Volume Market Share by Key Players 2012-2022
Figure Global Drugs of Nervous System Sales Volume Market Share by Key Players 2016
Figure Global Drugs of Nervous System Sales Volume Market Share by Key Players 2017
Table Global Drugs of Nervous System Revenue (Million USD) by Key Players 2012-2022
Table Global Drugs of Nervous System Revenue Market Share by Key Players 2012-2022
Figure Global Drugs of Nervous System Revenue Market Share by Key Players 2016
Figure Global Drugs of Nervous System Revenue Market Share by Key Players 2017
Table Global Key Players Key Product Model and Market Performance
Table Global Key Players Key Target Consumers and Market Performance
Table Global Drugs of Nervous System Sales (MT) by Regions (2012-2022)
Table Global Drugs of Nervous System Sales Share by Regions (2012-2022)
Figure Global Drugs of Nervous System Sales Market Share by Regions in 2016
Figure Global Drugs of Nervous System Sales Market Share by Regions in 2017
Table Global Drugs of Nervous System Revenue (Million USD) and Market Share by Regions (2012-2022)
Table Global Drugs of Nervous System Revenue Market Share by Regions (2012-2022)
Figure Global Drugs of Nervous System Revenue Market Share by Regions in 2016
Figure Global Drugs of Nervous System Revenue Market Share by Regions in 2017
Table Global Drugs of Nervous System Price (USD/T) by Regions (2012-2022)
Table Top Brands of United States Drugs of Nervous System Business Strategy, Channel and Performance List
Figure United States Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Europe Drugs of Nervous System Business Strategy, Channel and Performance List
Figure Europe Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of China Drugs of Nervous System Business Strategy, Channel and Performance List
Figure China Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Japan Drugs of Nervous System Business Strategy, Channel and Performance List
Figure Japan Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of India Drugs of Nervous System Business Strategy, Channel and Performance List
Figure India Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Southeast Asia Drugs of Nervous System Business Strategy, Channel and Performance List
Figure Southeast Asia Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Others Drugs of Nervous System Business Strategy, Channel and Performance List
Figure Others Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Global Drugs of Nervous System Sales (MT) by Product Antiparkinsonism drugs(2012-2022)
Table Global Drugs of Nervous System Sales Market Share by Product Antiparkinsonism drugs(2012-2022)
Figure Global Drugs of Nervous System Sales Market Share by Product Antiparkinsonism drugsin 2016
Table Global Drugs of Nervous System Revenue (Million USD) by Product Antiparkinsonism drugs(2012-2022)
Table Global Drugs of Nervous System Revenue Market Share by Product Antiparkinsonism drugs(2012-2022)
Figure Global Drugs of Nervous System Revenue Market Share by Product Antiparkinsonism drugsin 2016
Table Global Drugs of Nervous System Price (USD/T) by Product Antiparkinsonism drugs(2012-2022)
Table Top Brands of L-Dopa Drugs of Nervous System Products List
Figure Global L-Dopa Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Carbidopa Drugs of Nervous System Products List
Figure Global Carbidopa Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Benserazide Drugs of Nervous System Products List
Figure Global Benserazide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Sinemet Drugs of Nervous System Products List
Figure Global Sinemet Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Selegiline Drugs of Nervous System Products List
Figure Global Selegiline Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Amantadine Drugs of Nervous System Products List
Figure Global Amantadine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Bromocriptine Drugs of Nervous System Products List
Figure Global Bromocriptine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Pergolide Drugs of Nervous System Products List
Figure Global Pergolide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Artane Drugs of Nervous System Products List
Figure Global Artane Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Global Drugs of Nervous System Sales (MT) by Product Antimyasthenics (2012-2022)
Table Global Drugs of Nervous System Sales Market Share by Product Antimyasthenics (2012-2022)
Figure Global Drugs of Nervous System Sales Market Share by Product Antimyasthenics in 2016
Table Global Drugs of Nervous System Revenue (Million USD) by Product Antimyasthenics (2012-2022)
Table Global Drugs of Nervous System Revenue Market Share by Product Antimyasthenics (2012-2022)
Figure Global Drugs of Nervous System Revenue Market Share by Product Antimyasthenics in 2016
Table Global Drugs of Nervous System Price (USD/T) by Product Antimyasthenics (2012-2022)
Table Top Brands of Neostigmine Drugs of Nervous System Products List
Figure Global Neostigmine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Neostigmine Methylsulfate Drugs of Nervous System Products List
Figure Global Neostigmine Methylsulfate Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Pyridostigmine Bromide Drugs of Nervous System Products List
Figure Global Pyridostigmine Bromide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Galanthamine Drugs of Nervous System Products List
Figure Global Galanthamine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Edrophonium Chloride Drugs of Nervous System Products List
Figure Global Edrophonium Chloride Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Ambestigmin Drugs of Nervous System Products List
Figure Global Ambestigmin Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Global Drugs of Nervous System Sales (MT) by Product Antiepileptics (2012-2022)
Table Global Drugs of Nervous System Sales Market Share by Product Antiepileptics (2012-2022)
Figure Global Drugs of Nervous System Sales Market Share by Product Antiepileptics in 2016
Table Global Drugs of Nervous System Revenue (Million USD) by Product Antiepileptics (2012-2022)
Table Global Drugs of Nervous System Revenue Market Share by Product Antiepileptics (2012-2022)
Figure Global Drugs of Nervous System Revenue Market Share by Product Antiepileptics in 2016
Table Global Drugs of Nervous System Price (USD/T) by Product Antiepileptics (2012-2022)
Table Top Brands of Phenytoin Sodium Drugs of Nervous System Products List
Figure Global Phenytoin Sodium Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Carbamazepine Drugs of Nervous System Products List
Figure Global Carbamazepine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Phenobarbital Drugs of Nervous System Products List
Figure Global Phenobarbital Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Primidone Drugs of Nervous System Products List
Figure Global Primidone Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Ethosuximide Drugs of Nervous System Products List
Figure Global Ethosuximide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Sodium valproate Drugs of Nervous System Products List
Figure Global Sodium valproate Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Clonazepam Drugs of Nervous System Products List
Figure Global Clonazepam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Trimethadione Drugs of Nervous System Products List
Figure Global Trimethadione Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Lamotrigine Drugs of Nervous System Products List
Figure Global Lamotrigine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Sultiame Drugs of Nervous System Products List
Figure Global Sultiame Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Felbamate Drugs of Nervous System Products List
Figure Global Felbamate Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Levetiracetam Drugs of Nervous System Products List
Figure Global Levetiracetam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Topamax Drugs of Nervous System Products List
Figure Global Topamax Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Global Drugs of Nervous System Sales (MT) by Product Cerebrovascular disease drugs (2012-2022)
Table Global Drugs of Nervous System Sales Market Share by Product Cerebrovascular disease drugs (2012-2022)
Figure Global Drugs of Nervous System Sales Market Share by Product Cerebrovascular disease drugs in 2016
Table Global Drugs of Nervous System Revenue (Million USD) by Product Cerebrovascular disease drugs (2012-2022)
Table Global Drugs of Nervous System Revenue Market Share by Product Cerebrovascular disease drugs (2012-2022)
Figure Global Drugs of Nervous System Revenue Market Share by Product Cerebrovascular disease drugs in 2016
Table Global Drugs of Nervous System Price (USD/T) by Product Cerebrovascular disease drugs (2012-2022)
Table Top Brands of Nimodipine Drugs of Nervous System Products List
Figure Global Nimodipine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Carfergot Drugs of Nervous System Products List
Figure Global Carfergot Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Mannitol Drugs of Nervous System Products List
Figure Global Mannitol Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Acetazolamide Drugs of Nervous System Products List
Figure Global Acetazolamide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Piracetam Drugs of Nervous System Products List
Figure Global Piracetam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Global Drugs of Nervous System Sales (MT) by Product Sedative-hypnotic drugs (2012-2022)
Table Global Drugs of Nervous System Sales Market Share by Product Sedative-hypnotic drugs (2012-2022)
Figure Global Drugs of Nervous System Sales Market Share by Product Sedative-hypnotic drugs in 2016
Table Global Drugs of Nervous System Revenue (Million USD) by Product Sedative-hypnotic drugs (2012-2022)
Table Global Drugs of Nervous System Revenue Market Share by Product Sedative-hypnotic drugs (2012-2022)
Figure Global Drugs of Nervous System Revenue Market Share by Product Sedative-hypnotic drugs in 2016
Table Global Drugs of Nervous System Price (USD/T) by Product Sedative-hypnotic drugs (2012-2022)
Table Top Brands of Diazepam Drugs of Nervous System Products List
Figure Global Diazepam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Chlordiazepoxide Drugs of Nervous System Products List
Figure Global Chlordiazepoxide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Oxazepam Drugs of Nervous System Products List
Figure Global Oxazepam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Nitrazepam Drugs of Nervous System Products List
Figure Global Nitrazepam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Flunitrazepam Drugs of Nervous System Products List
Figure Global Flunitrazepam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Estazolam Drugs of Nervous System Products List
Figure Global Estazolam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Lorazepam Drugs of Nervous System Products List
Figure Global Lorazepam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Meprobamate Drugs of Nervous System Products List
Figure Global Meprobamate Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Hydroxyzine Drugs of Nervous System Products List
Figure Global Hydroxyzine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Captodiamine Drugs of Nervous System Products List
Figure Global Captodiamine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Piperilate Drugs of Nervous System Products List
Figure Global Piperilate Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Chlormezanone Drugs of Nervous System Products List
Figure Global Chlormezanone Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Trimeprazine Tartrate Drugs of Nervous System Products List
Figure Global Trimeprazine Tartrate Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Trimetozine Drugs of Nervous System Products List
Figure Global TrimetozineCaptodiamine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Oryzanol Drugs of Nervous System Products List
Figure Global Oryzanol Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Benzoctamine Drugs of Nervous System Products List
Figure Global Benzoctamine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Gastrodine Drugs of Nervous System Products List
Figure Global Gastrodine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Glutethimide Drugs of Nervous System Products List
Figure Global Glutethimide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Global Drugs of Nervous System Sales (MT) by Product Sedative-hypnotic drugs (2012-2022)
Table Global Drugs of Nervous System Sales Market Share by Product Sedative-hypnotic drugs (2012-2022)
Figure Global Drugs of Nervous System Sales Market Share by Product Sedative-hypnotic drugs in 2016
Table Global Drugs of Nervous System Revenue (Million USD) by Product Sedative-hypnotic drugs (2012-2022)
Table Global Drugs of Nervous System Revenue Market Share by Product Sedative-hypnotic drugs (2012-2022)
Figure Global Drugs of Nervous System Revenue Market Share by Product Sedative-hypnotic drugs in 2016
Table Global Drugs of Nervous System Price (USD/T) by Product Sedative-hypnotic drugs (2012-2022)
Table Top Brands of Citicoline Drugs of Nervous System Products List
Figure Global Citicoline Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Nikethamide Drugs of Nervous System Products List
Figure Global Nikethamide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Lobeline Drugs of Nervous System Products List
Figure Global Lobeline Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Piracetam Drugs of Nervous System Products List
Figure Global Piracetam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Ligustrazine Drugs of Nervous System Products List
Figure Global Ligustrazine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Flunarizine Drugs of Nervous System Products List
Figure Global Flunarizine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Cerebroprotein Hydrolysate Drugs of Nervous System Products List
Figure Global Cerebroprotein Hydrolysate Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Sodium Aescinate Drugs of Nervous System Products List
Figure Global Sodium Aescinate Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Troxerutin Drugs of Nervous System Products List
Figure Global Troxerutin Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Captodiamine Drugs of Nervous System Products List
Figure Global Captodiamine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table MSD PHARMA (SINGAPORE) PTE. LTD.Italy Company Details and Competitors
Table MSD PHARMA (SINGAPORE) PTE. LTD.Italy Key Drugs of Nervous System Models and Performance
Table MSD PHARMA (SINGAPORE) PTE. LTD.Italy Drugs of Nervous System Business SWOT Analysis and Forecast
Table MSD PHARMA (SINGAPORE) PTE. LTD.Italy Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure MSD PHARMA (SINGAPORE) PTE. LTD.Italy Drugs of Nervous System Sales(Million Unit) and Growth Rate (%) (2012-2022)
Figure MSD PHARMA (SINGAPORE) PTE. LTD.Italy Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure MSD PHARMA (SINGAPORE) PTE. LTD.Italy Drugs of Nervous System Sales Revenue(Million USD) and Growth Rate (%) (2012-2022)
Figure MSD PHARMA (SINGAPORE) PTE. LTD.Italy Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table Orion Corporation Finland Company Details and Competitors
Table Orion Corporation Finland Key Drugs of Nervous System Models and Performance
Table Orion Corporation Finland Drugs of Nervous System Business SWOT Analysis and Forecast
Table Orion Corporation Finland Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Orion Corporation Finland Drugs of Nervous System Sales(Million Unit) and Growth Rate (%) (2012-2022)
Figure Orion Corporation Finland Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure Orion Corporation Finland Drugs of Nervous System Sales Revenue(Million USD) and Growth Rate (%) (2012-2022)
Figure Orion Corporation Finland Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table Gedeon Richter Plc. Hungary Company Details and Competitors
Table Gedeon Richter Plc. Hungary Key Drugs of Nervous System Models and Performance
Table Gedeon Richter Plc. Hungary Drugs of Nervous System Business SWOT Analysis and Forecast
Table Gedeon Richter Plc. Hungary Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Gedeon Richter Plc. Hungary Drugs of Nervous System Sales(Million Unit) and Growth Rate (%) (2012-2022)
Figure Gedeon Richter Plc. Hungary Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure Gedeon Richter Plc. Hungary Drugs of Nervous System Sales Revenue(Million USD) and Growth Rate (%) (2012-2022)
Figure Gedeon Richter Plc. Hungary Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table Novartis Farma S.P.A. Italy Company Details and Competitors
Table Novartis Farma S.P.A. Italy Key Drugs of Nervous System Models and Performance
Table Novartis Farma S.P.A. Italy Drugs of Nervous System Business SWOT Analysis and Forecast
Table Novartis Farma S.P.A. Italy Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Novartis Farma S.P.A. Italy Drugs of Nervous System Sales(Million Unit) and Growth Rate (%) (2012-2022)
Figure Novartis Farma S.P.A. Italy Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure Novartis Farma S.P.A. Italy Drugs of Nervous System Sales Revenue(Million USD) and Growth Rate (%) (2012-2022)
Figure Novartis Farma S.P.A. Italy Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table Gedeon Richter Plc.Hungary Company Details and Competitors
Table Gedeon Richter Plc.Hungary Key Drugs of Nervous System Models and Performance
Table Gedeon Richter Plc.Hungary Drugs of Nervous System Business SWOT Analysis and Forecast
Table Gedeon Richter Plc.Hungary Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Gedeon Richter Plc.Hungary Drugs of Nervous System Sales(Million Unit) and Growth Rate (%) (2012-2022)
Figure Gedeon Richter Plc.Hungary Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure Gedeon Richter Plc.Hungary Drugs of Nervous System Sales Revenue(Million USD) and Growth Rate (%) (2012-2022)
Table Janssen Pharmaceutica N.V. Belgium Company Details and Competitors
Table Janssen Pharmaceutica N.V. Belgium Key Drugs of Nervous System Models and Performance
Table Janssen Pharmaceutica N.V. Belgium Drugs of Nervous System Business SWOT Analysis and Forecast
Table Janssen Pharmaceutica N.V. Belgium Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Janssen Pharmaceutica N.V. Belgium Drugs of Nervous System Sales(Million Unit) and Growth Rate (%) (2012-2022)
Figure Janssen Pharmaceutica N.V. Belgium Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure Janssen Pharmaceutica N.V. Belgium Drugs of Nervous System Sales Revenue(Million USD) and Growth Rate (%) (2012-2022)
Figure Janssen Pharmaceutica N.V. Belgium Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table Sanofi Aventis GmbH France Company Details and Competitors
Table Sanofi Aventis GmbH France Key Drugs of Nervous System Models and Performance
Table Sanofi Aventis GmbH France Drugs of Nervous System Business SWOT Analysis and Forecast
Table Sanofi Aventis GmbH France Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Sanofi Aventis GmbH France Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Sanofi Aventis GmbH France Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Figure Sanofi Aventis GmbH France Drugs of Nervous System Sales Revenue (Million USD) and Growth Rate (%) (2012-2022)
Table Taiwan Biotech Co.Ltd Company Details and Competitors
Table Taiwan Biotech Co.Ltd Key Drugs of Nervous System Models and Performance
Table Taiwan Biotech Co.Ltd Drugs of Nervous System Business SWOT Analysis and Forecast
Table Taiwan Biotech Co.Ltd Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Taiwan Biotech Co.Ltd Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Taiwan Biotech Co.Ltd Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure Taiwan Biotech Co.Ltd Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table GlaxoSmithKline Pharmaceuticals S.A.Poland Company Details and Competitors
Table GlaxoSmithKline Pharmaceuticals S.A.Poland Key Drugs of Nervous System Models and Performance
Table GlaxoSmithKline Pharmaceuticals S.A.Poland Drugs of Nervous System Business SWOT Analysis and Forecast
Table GlaxoSmithKline Pharmaceuticals S.A.Poland Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure GlaxoSmithKline Pharmaceuticals S.A.Poland Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure GlaxoSmithKline Pharmaceuticals S.A.Poland Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure GlaxoSmithKline Pharmaceuticals S.A.Poland Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table Actavis hf. Iceland Company Details and Competitors
Table Actavis hf. Iceland Key Drugs of Nervous System Models and Performance
Table Actavis hf. Iceland Drugs of Nervous System Business SWOT Analysis and Forecast
Table Actavis hf. Iceland Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Actavis hf. Iceland Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Actavis hf. Iceland Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure Actavis hf. Iceland Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table UCB Pharma S.A.Belgium Company Details and Competitors
Table UCB Pharma S.A.Belgium Key Drugs of Nervous System Models and Performance
Table UCB Pharma S.A.Belgium Drugs of Nervous System Business SWOT Analysis and Forecast
Table UCB Pharma S.A.Belgium Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure UCB Pharma S.A.Belgium Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure UCB Pharma S.A.Belgium Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure UCB Pharma S.A.Belgium Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table Janssen-Cilag AG Puerto Rico Company Details and Competitors
Table Janssen-Cilag AG Puerto Rico Key Drugs of Nervous System Models and Performance
Table Janssen-Cilag AG Puerto Rico Drugs of Nervous System Business SWOT Analysis and Forecast
Figure Janssen-Cilag AG Puerto Rico Drugs of Nervous System Product Picture
Table Janssen-Cilag AG Puerto Rico Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Janssen-Cilag AG Puerto Rico Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Janssen-Cilag AG Puerto Rico Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure Janssen-Cilag AG Puerto Rico Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table Bayer Vital GmbH Germany Company Details and Competitors
Table Bayer Vital GmbH Germany Key Drugs of Nervous System Models and Performance
Table Bayer Vital GmbH Germany Drugs of Nervous System Business SWOT Analysis and Forecast
Table Bayer Vital GmbH Germany Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Bayer Vital GmbH Germany Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Bayer Vital GmbH Germany Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure Bayer Vital GmbH Germany Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table Pfizer Pharmaceuticals Inc. Company Details and Competitors
Table Pfizer Pharmaceuticals Inc. Key Drugs of Nervous System Models and Performance
Table Pfizer Pharmaceuticals Inc. Drugs of Nervous System Business SWOT Analysis and Forecast
Figure Pfizer Pharmaceuticals Inc. Drugs of Nervous System Product Picture
Table Pfizer Pharmaceuticals Inc. Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Pfizer Pharmaceuticals Inc. Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Pfizer Pharmaceuticals Inc. Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure Pfizer Pharmaceuticals Inc. Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table PATHEON AUSTRIA GMBH & CO. KG AT Linz Company Details and Competitors
Table PATHEON AUSTRIA GMBH & CO. KG AT Linz Key Drugs of Nervous System Models and Performance
Table PATHEON AUSTRIA GMBH & CO. KG AT Linz Drugs of Nervous System Business SWOT Analysis and Forecast
Figure PATHEON AUSTRIA GMBH & CO. KG AT Linz Drugs of Nervous System Product Picture
Table PATHEON AUSTRIA GMBH & CO. KG AT Linz Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure PATHEON AUSTRIA GMBH & CO. KG AT Linz Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure PATHEON AUSTRIA GMBH & CO. KG AT Linz Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure PATHEON AUSTRIA GMBH & CO. KG AT Linz Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table ALKALOIDA CHEMICAL Tiszavasvari Company Details and Competitors
Table ALKALOIDA CHEMICAL Tiszavasvari Key Drugs of Nervous System Models and Performance
Table ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Business SWOT Analysis and Forecast
Figure ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Product Picture
Table ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table Siegfried Ltd CH 4800 Zofingen Company Details and Competitors
Table Siegfried Ltd CH 4800 Zofingen Key Drugs of Nervous System Models and Performance
Table Siegfried Ltd CH 4800 Zofingen Drugs of Nervous System Business SWOT Analysis and Forecast
Figure Siegfried Ltd CH 4800 Zofingen Drugs of Nervous System Product Picture
Table Siegfried Ltd CH 4800 Zofingen Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Siegfried Ltd CH 4800 Zofingen Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Siegfried Ltd CH 4800 Zofingen Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure Siegfried Ltd CH 4800 Zofingen Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table KATWIJK CHEMIE BV NL BA Katwijk ZH Company Details and Competitors
Table KATWIJK CHEMIE BV NL BA Katwijk ZH Key Drugs of Nervous System Models and Performance
Table KATWIJK CHEMIE BV NL BA Katwijk ZH Drugs of Nervous System Business SWOT Analysis and Forecast
Figure KATWIJK CHEMIE BV NL BA Katwijk ZH Drugs of Nervous System Product Picture
Table KATWIJK CHEMIE BV NL BA Katwijk ZH Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure KATWIJK CHEMIE BV NL BA Katwijk ZH Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure KATWIJK CHEMIE BV NL BA Katwijk ZH Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure KATWIJK CHEMIE BV NL BA Katwijk ZH Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Company Details and Competitors
Table F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Key Drugs of Nervous System Models and Performance
Table F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Drugs of Nervous System Business SWOT Analysis and Forecast
Figure F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Drugs of Nervous System Product Picture
Table F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Drugs of Nervous System Sales Market Share (%) in Global (2012-2022)
Figure F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Drugs of Nervous System Revenue Market Share (%) in Global (2012-2022)
Table Ergypharm FR 67452 Mundolsheim Company Details and Competitors
Table Ergypharm FR 67452 Mundolsheim Key Drugs of Nervous System Models and Performance
Table Ergypharm FR 67452 Mundolsheim Drugs of Nervous System Business SWOT Analysis and Forecast
Figure Ergypharm FR 67452 Mundolsheim Drugs of Nervous System Product Picture
Table Ergypharm FR 67452 Mundolsheim Drugs of Nervous System Outpu